Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03424746 · ClinicalTrials.gov registry record · Early Phase 1
Chelation Therapy in Diabetic Patients With Critical Limb Ischemia
A Early Phase 1 study, sponsored by Mt. Sinai Medical Center, Miami.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 11
- Enrollment target
NCT03424746 is a Early Phase 1 study that has completed, run by Mt. Sinai Medical Center, Miami. The registered enrollment target is 11 participants.
The verdict
NCT03424746, a Early Phase 1 study, has completed, sponsored by Mt. Sinai Medical Center, Miami.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 11 participants
- Enrollment target
Study Summary
This is a Pilot Trial Using Chelation Therapy for Limb Preservation in Diabetic Patients with Critical Limb Ischemia.
Interventions
- DRUG disodium EDTA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2015-08 |
| Est. Completion | 2019-02-18 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03424746
The ClinicalTrials.gov registry entry for NCT03424746 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mt. Sinai Medical Center, Miami, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which disodium EDTA is the first listed.
NCT03424746 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03424746 about?
NCT03424746 is a clinical study titled "Chelation Therapy in Diabetic Patients With Critical Limb Ischemia". This is a Pilot Trial Using Chelation Therapy for Limb Preservation in Diabetic Patients with Critical Limb Ischemia.
What is the current status of trial NCT03424746?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 11 participants. The study started on 2015-08. Estimated completion is 2019-02-18.
What interventions are being tested in trial NCT03424746?
The interventions under investigation include: disodium EDTA (DRUG).
Who is sponsoring clinical trial NCT03424746?
This trial is sponsored by Mt. Sinai Medical Center, Miami, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.